Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Biological Chemistry
|
August 25, 1982
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase
M S Brower, P C Harpel
Annals of the New York Academy of Sciences
|
January 1, 1983
Alpha 2-macroglobulin: an introduction
P C Harpel, M S Brower
Blood
|
May 1, 1983
Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes
M S Brower, P C Harpel
Methods in Enzymology
|
January 1, 1990
Streptavidin-enzyme complexes in detection of antigens on western blots
C L Brakel, M S Brower, K Garry
Analytical Biochemistry
|
June 1, 1985
Immunodetection with streptavidin-acid phosphatase complex on Western blots
M S Brower, C L Brakel, K Garry
The Journal of Clinical Investigation
|
February 1, 1985
Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins
M S Brower, R I Levin, K Garry
Blood
|
March 1, 1987
Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity
M S Brower, D A Walz, K E Garry, et al.
Blood
|
October 1, 1989
Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells
B B Weksler, E A Jaffe, M S Brower, et al.
Biochemistry
|
April 10, 1990
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained
D V Brezniak, M S Brower, J I Witting, et al.
Medical and Pediatric Oncology
|
January 1, 1984
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients
M S Brower, M Coleman, M W Pasmantier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Biological Chemistry
|
August 25, 1982
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase
M S Brower, P C Harpel
Annals of the New York Academy of Sciences
|
January 1, 1983
Alpha 2-macroglobulin: an introduction
P C Harpel, M S Brower
Blood
|
May 1, 1983
Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes
M S Brower, P C Harpel
Methods in Enzymology
|
January 1, 1990
Streptavidin-enzyme complexes in detection of antigens on western blots
C L Brakel, M S Brower, K Garry
Analytical Biochemistry
|
June 1, 1985
Immunodetection with streptavidin-acid phosphatase complex on Western blots
M S Brower, C L Brakel, K Garry
The Journal of Clinical Investigation
|
February 1, 1985
Human neutrophil elastase modulates platelet function by limited proteolysis of membrane glycoproteins
M S Brower, R I Levin, K Garry
Blood
|
March 1, 1987
Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity
M S Brower, D A Walz, K E Garry, et al.
Blood
|
October 1, 1989
Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells
B B Weksler, E A Jaffe, M S Brower, et al.
Biochemistry
|
April 10, 1990
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained
D V Brezniak, M S Brower, J I Witting, et al.
Medical and Pediatric Oncology
|
January 1, 1984
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients
M S Brower, M Coleman, M W Pasmantier, et al.
Page
of 1